RAMIPRIL

RAMIPRIL was reported 125006 times

RAMIPRIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL HIATUS HERNIA 157 0.6886
1 GRIP STRENGTH 137 0.5983
2 SWOLLEN JOINT COUNT 118 0.4720
3 LUPUS VULGARIS 561 0.4452
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 835 0.4169
5 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 220 0.3922
6 HYPOCHOLESTEROLAEMIA 131 0.3711
7 RHEUMATIC FEVER 1627 0.3646
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 238 0.3563
9 C-REACTIVE PROTEIN 329 0.3549
10 SWOLLEN JOINT COUNT INCREASED 1119 0.3506
11 FACET JOINT SYNDROME 1122 0.3443
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 645 0.3110
13 X-RAY ABNORMAL 549 0.3067
14 DISLOCATION OF VERTEBRA 681 0.2983
15 PERIPHERAL VENOUS DISEASE 1156 0.2828
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1934 0.2697
17 DUODENAL ULCER PERFORATION 1989 0.2672
18 RHEUMATOID FACTOR POSITIVE 1471 0.2544
19 RETINITIS 427 0.2470
20 PEMPHIGUS 2761 0.2206
21 MUSCLE INJURY 1628 0.1963
22 C-REACTIVE PROTEIN ABNORMAL 1227 0.1911
23 HELICOBACTER INFECTION 1940 0.1886
24 CATARRH 168 0.1858
25 HAND DEFORMITY 2409 0.1835
26 NEUROLOGIC NEGLECT SYNDROME 101 0.1817
27 STEROID DEPENDENCE 158 0.1800
28 PORPHYRIA ACUTE 251 0.1749
29 FOLLICULITIS 1789 0.1704
30 BREAST CANCER STAGE III 1074 0.1657
31 PRODUCT MONITORING ERROR 232 0.1606
32 OVERLAP SYNDROME 109 0.1557
33 CARDIAC SEPTAL DEFECT 109 0.1516
34 HYPERCHOLESTEROLAEMIA 1446 0.1496
35 ONYCHOMADESIS 590 0.1404
36 LIP DRY 1264 0.1390
37 PERICARDITIS 2337 0.1390
38 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 862 0.1326
39 SYNOVITIS 2327 0.1289
40 GRANULOMA SKIN 104 0.1267
41 BONE EROSION 444 0.1254
42 BLEPHAROSPASM 757 0.1201
43 GLOSSODYNIA 2671 0.1192
44 CAROTID ARTERY THROMBOSIS 100 0.1178
45 WOUND INFECTION 1285 0.1172
46 BURSITIS 1394 0.1148
47 SYSTEMIC INFECTION 190 0.1145
48 GRIP STRENGTH DECREASED 980 0.1112
49 DRUG TOLERANCE DECREASED 311 0.1106
50 JOINT RANGE OF MOTION DECREASED 1470 0.1095
51 LIVER INJURY 2668 0.1086
52 RECALLED PRODUCT ADMINISTERED 1031 0.1080
53 LIVE BIRTH 874 0.1044
54 ONYCHOMYCOSIS 448 0.1020
55 JOINT DESTRUCTION 156 0.1003
56 BURNS SECOND DEGREE 175 0.0997
57 SERONEGATIVE ARTHRITIS 111 0.0969
58 WOUND 2684 0.0959
59 BLOOD PRESSURE DIASTOLIC ABNORMAL 238 0.0935
60 AUTOIMMUNE DISORDER 860 0.0881
61 SYSTOLIC DYSFUNCTION 90 0.0854
62 NAIL DISORDER 747 0.0853
63 OBESITY 1343 0.0842
64 SYSTEMIC LUPUS ERYTHEMATOSUS 2935 0.0826
65 CONTRAINDICATED PRODUCT ADMINISTERED 2493 0.0823
66 IRRITABLE BOWEL SYNDROME 1732 0.0807
67 FIBROMYALGIA 1960 0.0805
68 MALIGNANT MELANOMA IN SITU 99 0.0799
69 ADJUSTMENT DISORDER 97 0.0746
70 PULMONARY FIBROSIS 1426 0.0743
71 BLOOD PARATHYROID HORMONE DECREASED 110 0.0742
72 FINGER DEFORMITY 358 0.0738
73 PUSTULAR PSORIASIS 250 0.0727
74 TYPE 2 DIABETES MELLITUS 2372 0.0704
75 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 162 0.0703
76 INFUSION SITE REACTION 208 0.0696
77 PSORIATIC ARTHROPATHY 2808 0.0691
78 SCIATICA 1085 0.0680
79 BLOOD PRESSURE SYSTOLIC ABNORMAL 166 0.0671
80 EXOSTOSIS 587 0.0642
81 NONINFECTIVE GINGIVITIS 93 0.0642
82 BREATH SOUNDS ABNORMAL 314 0.0636
83 RED BLOOD CELL SEDIMENTATION RATE INCREASED 676 0.0610
84 CARDIAC FAILURE CHRONIC 258 0.0605
85 HYPERKALAEMIA 2096 0.0597
86 VENTRICULAR HYPOKINESIA 186 0.0579
87 PRODUCT LABEL CONFUSION 336 0.0576
88 IMPAIRED HEALING 1876 0.0571
89 TONGUE OEDEMA 212 0.0555
90 DYSPNOEA AT REST 161 0.0555
91 BRADYARRHYTHMIA 91 0.0553
92 HYPOPNOEA 191 0.0550
93 ALCOHOL POISONING 146 0.0545
94 ULCER HAEMORRHAGE 366 0.0540
95 HYPERTENSIVE CRISIS 600 0.0539
96 LOWER RESPIRATORY TRACT INFECTION 2445 0.0537
97 RHEUMATOID NODULE 148 0.0537
98 BACK INJURY 581 0.0534
99 RASH VESICULAR 257 0.0531
100 PERSONALITY DISORDER 139 0.0530
101 ARTHROPATHY 2943 0.0529
102 LEFT VENTRICULAR DYSFUNCTION 353 0.0526
103 BRONCHIECTASIS 354 0.0525
104 BENIGN PROSTATIC HYPERPLASIA 269 0.0520
105 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 460 0.0520
106 WALKING AID USER 343 0.0520
107 C-REACTIVE PROTEIN INCREASED 1888 0.0518
108 PRESCRIBED OVERDOSE 1003 0.0518
109 ORTHOPNOEA 162 0.0508
110 PANNICULITIS 121 0.0500
111 ATRIAL TACHYCARDIA 105 0.0500
112 BREAST CANCER STAGE II 409 0.0491
113 DIASTOLIC DYSFUNCTION 151 0.0489
114 MYOSITIS 432 0.0481
115 BLOOD CHOLESTEROL INCREASED 2240 0.0480
116 MATERNAL EXPOSURE TIMING UNSPECIFIED 180 0.0479
117 VENTRICULAR DYSFUNCTION 124 0.0477
118 TACHYARRHYTHMIA 119 0.0476
119 LOWER LIMB FRACTURE 912 0.0474
120 EYE INJURY 144 0.0474
121 GENERAL PHYSICAL HEALTH DETERIORATION 5478 0.0473
122 LUPUS-LIKE SYNDROME 428 0.0471
123 AORTIC ARTERIOSCLEROSIS 121 0.0470
124 NIGHT SWEATS 1487 0.0461
125 CORONARY ARTERY STENOSIS 229 0.0455
126 DRUG TOLERANCE 230 0.0454
127 VENTRICULAR ARRHYTHMIA 164 0.0448
128 ANAEMIA MACROCYTIC 95 0.0445
129 FOOT DEFORMITY 490 0.0442
130 ORTHOSTATIC HYPOTENSION 768 0.0441
131 BLOOD PRESSURE DIASTOLIC DECREASED 325 0.0440
132 GAIT INABILITY 1466 0.0438
133 BUNDLE BRANCH BLOCK LEFT 186 0.0438
134 HYPONATRAEMIA 2439 0.0433
135 OSTEOARTHRITIS 1803 0.0425
136 AORTIC STENOSIS 148 0.0425
137 LICHENOID KERATOSIS 97 0.0424
138 HYPERPHOSPHATAEMIA 91 0.0423
139 TASTE DISORDER 851 0.0419
140 CONGENITAL ANOMALY 322 0.0416
141 HIP ARTHROPLASTY 636 0.0415
142 CONGESTIVE CARDIOMYOPATHY 173 0.0415
143 EJECTION FRACTION DECREASED 643 0.0413
144 ATRIOVENTRICULAR BLOCK FIRST DEGREE 176 0.0406
145 INFUSION RELATED REACTION 2665 0.0402
146 DUODENITIS 123 0.0401
147 BLOOD PRESSURE SYSTOLIC INCREASED 781 0.0400
148 PANCREATITIS NECROTISING 92 0.0400
149 LEFT VENTRICULAR FAILURE 136 0.0395
150 BLISTER 2212 0.0393
151 ELECTROLYTE IMBALANCE 457 0.0393
152 PRESCRIBED UNDERDOSE 777 0.0389
153 MITRAL VALVE INCOMPETENCE 439 0.0387
154 CAROTID ARTERY STENOSIS 134 0.0383
155 THERAPEUTIC PRODUCT EFFECT DECREASED 1707 0.0381
156 HEPATIC ENZYME INCREASED 2598 0.0381
157 POTENTIATING DRUG INTERACTION 127 0.0378
158 WHEEZING 2236 0.0377
159 MUSCULOSKELETAL PAIN 1945 0.0371
160 GASTRITIS EROSIVE 173 0.0371
161 ACUTE CORONARY SYNDROME 305 0.0368
162 ACUTE KIDNEY INJURY 5588 0.0365
163 GLOMERULAR FILTRATION RATE DECREASED 448 0.0364
164 ANGINA PECTORIS 1043 0.0364
165 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 622 0.0362
166 NORMAL NEWBORN 197 0.0362
167 LEFT VENTRICULAR HYPERTROPHY 155 0.0362
168 MELAENA 795 0.0361
169 LABYRINTHITIS 91 0.0360
170 RALES 209 0.0360
171 ANGIOEDEMA 1590 0.0359
172 HYPOVOLAEMIC SHOCK 172 0.0359
173 COELIAC DISEASE 352 0.0358
174 BLOOD CREATINE INCREASED 158 0.0357
175 MOBILITY DECREASED 2543 0.0354
176 LACTIC ACIDOSIS 1146 0.0354
177 PEMPHIGOID 264 0.0349
178 OBSTRUCTIVE AIRWAYS DISORDER 389 0.0349
179 EPILEPSY 1067 0.0349
180 CIRCULATORY COLLAPSE 593 0.0348
181 ERYSIPELAS 174 0.0346
182 STUPOR 111 0.0345
183 LUNG DISORDER 1668 0.0340
184 HYPERLACTACIDAEMIA 91 0.0339
185 SOPOR 448 0.0338
186 BRADYCARDIA 1790 0.0337
187 UROSEPSIS 311 0.0337
188 EXERCISE TOLERANCE DECREASED 193 0.0335
189 COMA SCALE ABNORMAL 97 0.0334
190 RHEUMATOID ARTHRITIS 3798 0.0334
191 POLYARTHRITIS 176 0.0334
192 DELIRIUM 1154 0.0332
193 PATENT DUCTUS ARTERIOSUS 131 0.0330
194 TRICUSPID VALVE INCOMPETENCE 262 0.0329
195 BODY TEMPERATURE DECREASED 324 0.0329
196 HEPATIC CIRRHOSIS 618 0.0329
197 STOMATITIS 1984 0.0327
198 OEDEMA 1770 0.0326
199 SKIN NECROSIS 169 0.0325
200 ELECTROCARDIOGRAM ABNORMAL 255 0.0325
201 EUGLYCAEMIC DIABETIC KETOACIDOSIS 134 0.0324
202 INFLAMMATION 1672 0.0324
203 DISCOMFORT 1974 0.0323
204 IRON DEFICIENCY 145 0.0322
205 RENAL FAILURE ACUTE 1361 0.0320
206 SWOLLEN TONGUE 1000 0.0320
207 CEREBRAL HAEMATOMA 107 0.0318
208 LIVER FUNCTION TEST INCREASED 680 0.0316
209 HYPOMAGNESAEMIA 438 0.0314
210 BLOOD PRESSURE SYSTOLIC DECREASED 143 0.0314
211 BLOOD PRESSURE DIASTOLIC INCREASED 143 0.0310
212 HYPOVOLAEMIA 181 0.0309
213 SWELLING 2893 0.0309
214 CEREBRAL ISCHAEMIA 159 0.0309
215 PRODUCT PRESCRIBING ERROR 730 0.0306
216 RED CELL DISTRIBUTION WIDTH INCREASED 126 0.0303
217 COLITIS MICROSCOPIC 143 0.0302
218 ATRIOVENTRICULAR BLOCK COMPLETE 202 0.0301
219 AORTIC VALVE INCOMPETENCE 128 0.0301
220 CONFUSIONAL STATE 4858 0.0300
221 KNEE ARTHROPLASTY 632 0.0300
222 PAROSMIA 226 0.0299
223 LOOSE TOOTH 96 0.0298
224 ARTERIOSCLEROSIS CORONARY ARTERY 197 0.0297
225 ABNORMAL LOSS OF WEIGHT 202 0.0296
226 CARDIAC MURMUR 256 0.0296
227 DERMATITIS EXFOLIATIVE 148 0.0295
228 TROPONIN INCREASED 225 0.0295
229 GINGIVAL PAIN 232 0.0291
230 ANURIA 250 0.0290
231 JOINT DISLOCATION 307 0.0290
232 MUSCULOSKELETAL STIFFNESS 2531 0.0289
233 JOINT SWELLING 3483 0.0288
234 RECTAL HAEMORRHAGE 1236 0.0287
235 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 117 0.0286
236 SLEEP DISORDER 2022 0.0286
237 PRESYNCOPE 696 0.0286
238 DRUG INTOLERANCE 2759 0.0285
239 RHABDOMYOLYSIS 1183 0.0283
240 RHINITIS 228 0.0282
241 HEART DISEASE CONGENITAL 100 0.0282
242 ISCHAEMIC STROKE 504 0.0282
243 DUODENAL ULCER 199 0.0282
244 INTERNATIONAL NORMALISED RATIO INCREASED 803 0.0281
245 HEMIPLEGIA 233 0.0280
246 ANGINA UNSTABLE 182 0.0280
247 DRUG INTERACTION 4420 0.0278
248 EMBOLIC STROKE 98 0.0278
249 ANGIOPATHY 156 0.0278
250 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 282 0.0274
251 CARDIAC FAILURE 2188 0.0272
252 VENTRICULAR SEPTAL DEFECT 156 0.0272
253 ACUTE MYOCARDIAL INFARCTION 801 0.0271
254 GANGRENE 163 0.0270
255 INTENTIONAL PRODUCT USE ISSUE 2359 0.0269
256 MATERNAL EXPOSURE DURING PREGNANCY 2400 0.0269
257 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 136 0.0268
258 CAROTID ARTERY OCCLUSION 97 0.0266
259 HEPATITIS 677 0.0264
260 HEMIPARESIS 448 0.0264
261 LIP SWELLING 876 0.0263
262 CARDIOGENIC SHOCK 376 0.0262
263 SINUS BRADYCARDIA 252 0.0260
264 DRUG-INDUCED LIVER INJURY 817 0.0260
265 DRY MOUTH 2093 0.0258
266 BLOOD URIC ACID INCREASED 148 0.0256
267 SPONDYLITIS 93 0.0255
268 LIP OEDEMA 108 0.0255
269 HEPATITIS CHOLESTATIC 153 0.0254
270 TUBULOINTERSTITIAL NEPHRITIS 475 0.0253
271 INJURY 1781 0.0253
272 CHOLESTASIS 486 0.0253
273 HYPOGLYCAEMIA 1222 0.0252
274 ACUTE PULMONARY OEDEMA 141 0.0251
275 TENSION HEADACHE 108 0.0251
276 GENERAL SYMPTOM 187 0.0249
277 POLYP 163 0.0249
278 PANCREATITIS ACUTE 556 0.0247
279 HYPOKALAEMIA 1141 0.0247
280 POLYURIA 202 0.0246
281 SYNCOPE 2434 0.0243
282 MYOPATHY 210 0.0243
283 VENTRICULAR TACHYCARDIA 401 0.0243
284 BLOOD PRESSURE FLUCTUATION 579 0.0241
285 HYPERTENSION 5108 0.0241
286 HYPERURICAEMIA 99 0.0241
287 DYSPNOEA EXERTIONAL 907 0.0241
288 GAMMA-GLUTAMYLTRANSFERASE INCREASED 529 0.0238
289 ATRIAL FIBRILLATION 2319 0.0238
290 NEUTROPENIC SEPSIS 170 0.0238
291 OEDEMA PERIPHERAL 2892 0.0237
292 VENTRICULAR FIBRILLATION 263 0.0237
293 RESPIRATORY RATE INCREASED 210 0.0236
294 NEPHROTIC SYNDROME 162 0.0236
295 ILL-DEFINED DISORDER 1431 0.0235
296 URINE ABNORMALITY 107 0.0235
297 ROAD TRAFFIC ACCIDENT 981 0.0234
298 HYPERTHYROIDISM 337 0.0233
299 HAEMATOMA 603 0.0233
300 SUBARACHNOID HAEMORRHAGE 236 0.0231
301 HAEMATEMESIS 587 0.0231
302 PARKINSONISM 225 0.0231
303 ATRIOVENTRICULAR BLOCK 178 0.0230
304 HYPERTRANSAMINASAEMIA 160 0.0230
305 NOCTURIA 279 0.0230
306 OLIGURIA 142 0.0229
307 TREATMENT FAILURE 1884 0.0227
308 MOTOR DYSFUNCTION 231 0.0226
309 CORONARY ARTERY DISEASE 686 0.0226
310 SENSORY LOSS 182 0.0226
311 MEDICATION ERROR 1249 0.0224
312 BLOOD LACTIC ACID INCREASED 118 0.0224
313 FREQUENT BOWEL MOVEMENTS 605 0.0224
314 HEPATITIS ACUTE 145 0.0223
315 FAECALOMA 122 0.0222
316 METABOLIC ACIDOSIS 711 0.0222
317 HYPOTENSION 4454 0.0222
318 ADVERSE REACTION 294 0.0222
319 ABDOMINAL DISCOMFORT 3719 0.0221
320 GOUT 397 0.0221
321 JAUNDICE 589 0.0219
322 NEUTROPHIL COUNT INCREASED 224 0.0219
323 LIVER FUNCTION TEST ABNORMAL 634 0.0218
324 PALLOR 593 0.0218
325 HAEMATURIA 745 0.0217
326 EOSINOPHILIA 380 0.0217
327 ATRIAL SEPTAL DEFECT 181 0.0216
328 BUNDLE BRANCH BLOCK RIGHT 99 0.0215
329 FLANK PAIN 202 0.0215
330 SHOCK HAEMORRHAGIC 175 0.0215
331 HIATUS HERNIA 276 0.0213
332 BLOOD CREATINE PHOSPHOKINASE INCREASED 613 0.0213
333 LIVER DISORDER 939 0.0212
334 HEART RATE DECREASED 740 0.0211
335 ATRIAL FLUTTER 168 0.0210
336 MUSCULAR WEAKNESS 2380 0.0209
337 THERAPY NON-RESPONDER 941 0.0209
338 AGRANULOCYTOSIS 389 0.0209
339 HAEMATOCHEZIA 1152 0.0209
340 IMMOBILE 91 0.0208
341 EXPOSURE DURING PREGNANCY 1294 0.0208
342 TRANSIENT ISCHAEMIC ATTACK 702 0.0208
343 HYPOCALCAEMIA 393 0.0207
344 ARTERIAL OCCLUSIVE DISEASE 163 0.0207
345 COORDINATION ABNORMAL 289 0.0207
346 IRON DEFICIENCY ANAEMIA 191 0.0207
347 ACIDOSIS 158 0.0207
348 MOUTH SWELLING 119 0.0206
349 PERIPHERAL SWELLING 3175 0.0206
350 DRUG LEVEL ABOVE THERAPEUTIC 94 0.0205
351 TACHYPNOEA 279 0.0205
352 FLUID INTAKE REDUCED 102 0.0204
353 BLOOD POTASSIUM INCREASED 331 0.0204
354 GASTROINTESTINAL DISORDER 1825 0.0204
355 MICTURITION URGENCY 232 0.0203
356 BLOOD CREATININE INCREASED 1318 0.0202
357 UPPER GASTROINTESTINAL HAEMORRHAGE 339 0.0201
358 BASAL CELL CARCINOMA 314 0.0201
359 ELECTROCARDIOGRAM QT PROLONGED 723 0.0201
360 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 964 0.0200
361 CONTUSION 1924 0.0200
362 HYPERCALCAEMIA 246 0.0199
363 MYOCARDIAL ISCHAEMIA 226 0.0198
364 HYPOPHOSPHATAEMIA 146 0.0197
365 DYSPEPSIA 1937 0.0197
366 SUBDURAL HAEMATOMA 280 0.0195
367 RESPIRATORY DISORDER 585 0.0195
368 HYPERLIPIDAEMIA 233 0.0195
369 GASTRIC ULCER HAEMORRHAGE 108 0.0195
370 HEPATOCELLULAR INJURY 276 0.0194
371 EOSINOPHIL COUNT INCREASED 161 0.0193
372 POLYNEUROPATHY 231 0.0193
373 DIABETES MELLITUS INADEQUATE CONTROL 341 0.0192
374 STRESS CARDIOMYOPATHY 111 0.0191
375 BLOOD UREA INCREASED 319 0.0190
376 GASTROOESOPHAGEAL REFLUX DISEASE 1531 0.0190
377 CARDIOMYOPATHY 280 0.0189
378 DYSLIPIDAEMIA 96 0.0189
379 PROTHROMBIN TIME PROLONGED 113 0.0189
380 WHITE BLOOD CELL COUNT INCREASED 719 0.0187
381 CACHEXIA 96 0.0186
382 JOINT STIFFNESS 489 0.0186
383 RENAL CYST 148 0.0186
384 INTESTINAL ISCHAEMIA 102 0.0185
385 PETECHIAE 193 0.0185
386 BRADYKINESIA 109 0.0184
387 SPINAL OSTEOARTHRITIS 162 0.0184
388 ARTERIOSCLEROSIS 173 0.0184
389 VASCULITIS 214 0.0184
390 SKIN ULCER 474 0.0183
391 EAR PAIN 356 0.0183
392 HYPOTHERMIA 184 0.0182
393 LOW BIRTH WEIGHT BABY 144 0.0181
394 CHEST PAIN 3343 0.0180
395 TRANSAMINASES INCREASED 401 0.0180
396 PREGNANCY 361 0.0180
397 VENTRICULAR EXTRASYSTOLES 187 0.0180
398 ULCER 286 0.0180
399 WEIGHT FLUCTUATION 188 0.0180
400 POSTOPERATIVE WOUND INFECTION 121 0.0179
401 ARRHYTHMIA 847 0.0179
402 DYSARTHRIA 672 0.0178
403 DISABILITY 353 0.0178
404 CEREBRAL HAEMORRHAGE 639 0.0178
405 PULMONARY CONGESTION 235 0.0178
406 EAR INFECTION 474 0.0178
407 MIGRAINE 1699 0.0178
408 PURPURA 157 0.0177
409 ASPHYXIA 144 0.0176
410 DERMATITIS BULLOUS 127 0.0175
411 MYASTHENIA GRAVIS 141 0.0174
412 HYPOAESTHESIA 2607 0.0174
413 HYPERGLYCAEMIA 633 0.0174
414 POOR VENOUS ACCESS 179 0.0173
415 EXTRASYSTOLES 120 0.0172
416 DEHYDRATION 2292 0.0172
417 URINE ODOUR ABNORMAL 101 0.0172
418 CARDIOMEGALY 211 0.0171
419 JOINT EFFUSION 118 0.0171
420 LUNG INFILTRATION 151 0.0171
421 ARTHRITIS 1342 0.0170
422 CONCOMITANT DISEASE AGGRAVATED 105 0.0170
423 RENAL IMPAIRMENT 1428 0.0170
424 ALOPECIA 3333 0.0170
425 OSTEOPOROSIS 694 0.0169
426 HEPATIC STEATOSIS 314 0.0168
427 MYOCARDITIS 193 0.0168
428 NECK PAIN 940 0.0168
429 FULL BLOOD COUNT ABNORMAL 177 0.0167
430 MUSCLE SPASTICITY 205 0.0167
431 BLOOD PRESSURE INCREASED 2550 0.0167
432 HALLUCINATION, VISUAL 352 0.0167
433 GASTROENTERITIS 243 0.0166
434 BACK DISORDER 270 0.0166
435 ANAEMIA 3166 0.0166
436 URINE OUTPUT DECREASED 145 0.0166
437 ABDOMINAL PAIN UPPER 3413 0.0166
438 ADRENAL INSUFFICIENCY 201 0.0165
439 ERECTILE DYSFUNCTION 425 0.0165
440 DERMATITIS ALLERGIC 208 0.0165
441 PERIPHERAL COLDNESS 227 0.0165
442 CARDIAC FAILURE ACUTE 109 0.0163
443 URINARY RETENTION 544 0.0163
444 NASOPHARYNGITIS 3002 0.0163
445 DRUG LEVEL INCREASED 269 0.0162
446 LARYNGEAL OEDEMA 100 0.0162
447 AMNESIA 1054 0.0162
448 DIZZINESS POSTURAL 157 0.0162
449 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 273 0.0161
450 LIPASE INCREASED 123 0.0160
451 CONDITION AGGRAVATED 4879 0.0160
452 BLOOD CALCIUM DECREASED 180 0.0160
453 PARAESTHESIA 2504 0.0159
454 SHOCK 366 0.0159
455 SINUSITIS 1629 0.0159
456 PULMONARY OEDEMA 710 0.0158
457 SUPRAVENTRICULAR TACHYCARDIA 151 0.0158
458 RENAL FAILURE CHRONIC 121 0.0157
459 TOXIC EPIDERMAL NECROLYSIS 238 0.0157
460 MUSCLE TWITCHING 361 0.0156
461 DYSURIA 576 0.0156
462 VERTIGO 952 0.0156
463 TACHYCARDIA 1384 0.0156
464 COLITIS ISCHAEMIC 105 0.0155
465 OESOPHAGITIS 170 0.0155
466 MEMORY IMPAIRMENT 2135 0.0155
467 DISORIENTATION 614 0.0155
468 COLITIS ULCERATIVE 691 0.0154
469 BLOOD SODIUM DECREASED 291 0.0154
470 HEART RATE IRREGULAR 348 0.0154
471 SLEEP APNOEA SYNDROME 293 0.0153
472 FALL 5104 0.0153
473 COVID-19 PNEUMONIA 181 0.0153
474 BLOOD PRESSURE INADEQUATELY CONTROLLED 92 0.0153
475 BLOOD ALBUMIN DECREASED 121 0.0152
476 GASTRITIS 401 0.0152
477 RASH MACULO-PAPULAR 338 0.0152
478 SPINAL PAIN 177 0.0151
479 HEPATOMEGALY 148 0.0150
480 URTICARIA 2523 0.0150
481 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1067 0.0150
482 DYSPNOEA 8475 0.0150
483 KETOACIDOSIS 112 0.0150
484 POISONING DELIBERATE 141 0.0149
485 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 775 0.0148
486 GASTRIC ULCER 282 0.0148
487 APHASIA 448 0.0148
488 DECREASED APPETITE 3443 0.0148
489 BRADYPHRENIA 96 0.0147
490 IMPAIRED WORK ABILITY 313 0.0146
491 ABDOMINAL PAIN 3392 0.0146
492 PLEURAL EFFUSION 885 0.0145
493 ASTHMA 1637 0.0145
494 INFECTION 2095 0.0145
495 PROTEINURIA 275 0.0145
496 FAECES DISCOLOURED 313 0.0144
497 PLATELET COUNT INCREASED 188 0.0144
498 MUSCLE SPASMS 2631 0.0143
499 NODULE 187 0.0143
500 ASTHENIA 5372 0.0143
501 SUDDEN DEATH 151 0.0143
502 SQUAMOUS CELL CARCINOMA 134 0.0142
503 DIABETIC KETOACIDOSIS 341 0.0142
504 IMPAIRED QUALITY OF LIFE 204 0.0142
505 THIRST 253 0.0141
506 WEIGHT INCREASED 3171 0.0141
507 ALANINE AMINOTRANSFERASE INCREASED 866 0.0141
508 HYPERSENSITIVITY 2617 0.0141
509 SINUS CONGESTION 190 0.0140
510 ASPIRATION 154 0.0140
511 TINNITUS 644 0.0140
512 CHROMATURIA 316 0.0140
513 PROCTALGIA 90 0.0140
514 AFFECT LABILITY 134 0.0139
515 PALPITATIONS 1625 0.0139
516 DIZZINESS 6908 0.0138
517 MULTIPLE ORGAN DYSFUNCTION SYNDROME 390 0.0138
518 COLD SWEAT 242 0.0137
519 CORONARY ARTERY OCCLUSION 188 0.0137
520 VOMITING 6431 0.0137
521 NIGHTMARE 472 0.0136
522 BLOOD PRESSURE DECREASED 906 0.0136
523 CYSTITIS 434 0.0136
524 MOUTH ULCERATION 287 0.0136
525 LOSS OF CONSCIOUSNESS 1744 0.0136
526 PNEUMONIA 4387 0.0135
527 HAEMODYNAMIC INSTABILITY 103 0.0135
528 PANCYTOPENIA 755 0.0135
529 HYPOTONIA 134 0.0134
530 HEPATIC CYTOLYSIS 171 0.0134
531 MUSCLE RIGIDITY 160 0.0134
532 APNOEA 104 0.0133
533 RESTLESSNESS 488 0.0133
534 MYOCLONUS 159 0.0133
535 DRUG ERUPTION 236 0.0133
536 PRODUCT USE ISSUE 2496 0.0133
537 DEFAECATION URGENCY 93 0.0133
538 ASCITES 390 0.0133
539 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 103 0.0132
540 LIGAMENT SPRAIN 131 0.0132
541 VITAMIN D DEFICIENCY 129 0.0132
542 HAEMORRHAGIC STROKE 103 0.0132
543 GASTROINTESTINAL HAEMORRHAGE 1102 0.0132
544 ABDOMINAL PAIN LOWER 333 0.0132
545 HYPOKINESIA 191 0.0131
546 EPISTAXIS 983 0.0131
547 FACIAL PAIN 117 0.0131
548 PAIN IN EXTREMITY 3842 0.0130
549 HAEMOGLOBIN DECREASED 1335 0.0130
550 FACE OEDEMA 219 0.0130
551 RENAL TUBULAR NECROSIS 127 0.0129
552 PHARYNGEAL OEDEMA 199 0.0129
553 ACCIDENTAL OVERDOSE 473 0.0129
554 THROMBOCYTOPENIA 1438 0.0128
555 LETHARGY 739 0.0128
556 CLOSTRIDIUM DIFFICILE COLITIS 135 0.0127
557 OXYGEN SATURATION DECREASED 714 0.0127
558 TENDON PAIN 96 0.0127
559 ARTHRALGIA 5270 0.0127
560 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 326 0.0127
561 HAEMATOCRIT DECREASED 251 0.0126
562 LYMPHOPENIA 179 0.0126
563 HYPERBILIRUBINAEMIA 131 0.0126
564 SWELLING FACE 822 0.0126
565 TORSADE DE POINTES 99 0.0126
566 SKIN HAEMORRHAGE 187 0.0126
567 FACIAL PARALYSIS 107 0.0125
568 MOUTH HAEMORRHAGE 92 0.0125
569 PRODUCTIVE COUGH 599 0.0125
570 PULMONARY EMBOLISM 1192 0.0125
571 SINUS TACHYCARDIA 178 0.0125
572 LOW DENSITY LIPOPROTEIN INCREASED 97 0.0125
573 PULMONARY HYPERTENSION 261 0.0125
574 DIARRHOEA HAEMORRHAGIC 117 0.0125
575 RESPIRATORY TRACT INFECTION 326 0.0125
576 HAEMODIALYSIS 105 0.0125
577 MUSCLE STRAIN 108 0.0125
578 DISTURBANCE IN ATTENTION 673 0.0125
579 PARAESTHESIA ORAL 180 0.0125
580 RENAL FAILURE 1654 0.0124
581 VISUAL FIELD DEFECT 90 0.0124
582 TOOTH FRACTURE 136 0.0123
583 BLOOD ALKALINE PHOSPHATASE INCREASED 306 0.0123
584 URINARY INCONTINENCE 365 0.0123
585 MYALGIA 2093 0.0123
586 GAIT DISTURBANCE 2356 0.0123
587 FLUID RETENTION 625 0.0123
588 FEELING HOT 753 0.0123
589 LOCALISED INFECTION 296 0.0122
590 ERYTHEMA MULTIFORME 114 0.0122
591 MUSCULOSKELETAL CHEST PAIN 189 0.0122
592 PYREXIA 4224 0.0122
593 PANCREATITIS 645 0.0122
594 DEPRESSION 2776 0.0122
595 MUCOSAL INFLAMMATION 319 0.0122
596 SEPTIC SHOCK 530 0.0122
597 LEUKOPENIA 609 0.0122
598 PHARYNGEAL SWELLING 119 0.0122
599 BLOOD IRON DECREASED 144 0.0121
600 END STAGE RENAL DISEASE 221 0.0121
601 TOXIC SKIN ERUPTION 122 0.0121
602 SALIVARY HYPERSECRETION 121 0.0121
603 CEREBRAL INFARCTION 295 0.0121
604 RASH PRURITIC 651 0.0120
605 UNRESPONSIVE TO STIMULI 310 0.0120
606 RENAL PAIN 127 0.0120
607 MUSCULOSKELETAL DISCOMFORT 206 0.0120
608 ABDOMINAL DISTENSION 1249 0.0120
609 MALAISE 5231 0.0119
610 MULTI-ORGAN FAILURE 206 0.0119
611 EMPHYSEMA 120 0.0119
612 COUGH 3330 0.0119
613 APATHY 173 0.0118
614 DEPRESSED MOOD 626 0.0118
615 IMMUNODEFICIENCY 176 0.0118
616 CHOLELITHIASIS 387 0.0118
617 APPENDICITIS 110 0.0118
618 GROIN PAIN 103 0.0117
619 FRACTURE 222 0.0117
620 ACUTE RESPIRATORY FAILURE 225 0.0117
621 HAEMOPTYSIS 326 0.0117
622 HALLUCINATION 880 0.0117
623 BLOOD CALCIUM INCREASED 102 0.0116
624 LEUKOCYTOSIS 210 0.0116
625 DEPRESSED LEVEL OF CONSCIOUSNESS 459 0.0116
626 TOOTH ABSCESS 118 0.0116
627 TENDON RUPTURE 143 0.0116
628 ASPARTATE AMINOTRANSFERASE INCREASED 615 0.0116
629 ACUTE HEPATIC FAILURE 158 0.0116
630 HYPOPHAGIA 295 0.0115
631 NEURALGIA 280 0.0115
632 HAEMORRHAGE INTRACRANIAL 172 0.0115
633 BLOOD GLUCOSE FLUCTUATION 126 0.0115
634 CHEST DISCOMFORT 1177 0.0115
635 DIPLOPIA 298 0.0115
636 RIB FRACTURE 236 0.0115
637 WEIGHT DECREASED 3201 0.0115
638 PNEUMONIA ASPIRATION 286 0.0114
639 PHOTOSENSITIVITY REACTION 189 0.0114
640 CARDIAC ARREST 943 0.0114
641 GASTROINTESTINAL INFECTION 102 0.0114
642 DIARRHOEA 7307 0.0113
643 BLOOD PRESSURE ABNORMAL 225 0.0113
644 SEROTONIN SYNDROME 217 0.0113
645 JOINT INJURY 241 0.0113
646 SKIN PLAQUE 95 0.0113
647 PERICARDIAL EFFUSION 260 0.0112
648 STATUS EPILEPTICUS 126 0.0111
649 LIMB DISCOMFORT 345 0.0111
650 GENERALISED OEDEMA 138 0.0111
651 SKIN LACERATION 121 0.0111
652 DIABETES MELLITUS 847 0.0111
653 SEPSIS 1238 0.0111
654 DEMENTIA 310 0.0111
655 HICCUPS 91 0.0111
656 PYELONEPHRITIS 96 0.0111
657 TENDERNESS 115 0.0110
658 CHOLECYSTITIS 131 0.0110
659 CELLULITIS 554 0.0110
660 FEELING COLD 306 0.0110
661 DRUG PRESCRIBING ERROR 210 0.0109
662 RESPIRATORY TRACT CONGESTION 172 0.0108
663 SECOND PRIMARY MALIGNANCY 90 0.0108
664 RASH 4707 0.0108
665 BLOOD LACTATE DEHYDROGENASE INCREASED 171 0.0108
666 BLOOD URINE PRESENT 204 0.0107
667 FATIGUE 8326 0.0107
668 BLADDER DISORDER 106 0.0107
669 RESTLESS LEGS SYNDROME 194 0.0107
670 BLOOD BILIRUBIN INCREASED 286 0.0106
671 GINGIVAL BLEEDING 144 0.0105
672 PNEUMONITIS 287 0.0105
673 BODY TEMPERATURE INCREASED 214 0.0105
674 PERSONALITY CHANGE 97 0.0104
675 MYOCARDIAL INFARCTION 1821 0.0104
676 DYSPHAGIA 990 0.0104
677 VISUAL IMPAIRMENT 1292 0.0104
678 INTERSTITIAL LUNG DISEASE 504 0.0104
679 INCONTINENCE 110 0.0104
680 ORAL CANDIDIASIS 137 0.0104
681 DEEP VEIN THROMBOSIS 675 0.0104
682 ATAXIA 123 0.0104
683 ATELECTASIS 100 0.0103
684 BACTERIAL INFECTION 193 0.0103
685 MUSCLE ATROPHY 131 0.0103
686 LYMPHOCYTE COUNT DECREASED 182 0.0103
687 DEVICE RELATED INFECTION 158 0.0103
688 CYANOSIS 160 0.0102
689 PRODUCT USE IN UNAPPROVED INDICATION 2520 0.0102
690 ECZEMA 532 0.0102
691 ANAPHYLACTIC REACTION 561 0.0101
692 COGNITIVE DISORDER 473 0.0101
693 SENSORY DISTURBANCE 162 0.0101
694 HYPOTHYROIDISM 322 0.0101
695 THROMBOTIC MICROANGIOPATHY 98 0.0100
696 POST PROCEDURAL HAEMORRHAGE 117 0.0100
697 RETINAL DETACHMENT 92 0.0100
698 COLITIS 378 0.0100
699 DIVERTICULITIS 276 0.0099
700 TENDONITIS 154 0.0099
701 INSOMNIA 2643 0.0099
702 STEVENS-JOHNSON SYNDROME 220 0.0099
703 HEAD INJURY 312 0.0098
704 SINUS DISORDER 195 0.0098
705 PAIN 6031 0.0098
706 HYPERHIDROSIS 1264 0.0098
707 PRODUCT ADMINISTRATION ERROR 198 0.0098
708 LABORATORY TEST ABNORMAL 288 0.0097
709 DRUG LEVEL DECREASED 99 0.0097
710 COAGULOPATHY 162 0.0097
711 NAUSEA 7673 0.0097
712 OROPHARYNGEAL PAIN 895 0.0097
713 BALANCE DISORDER 832 0.0096
714 EATING DISORDER 204 0.0096
715 HEART RATE INCREASED 948 0.0096
716 GASTROENTERITIS VIRAL 172 0.0095
717 MASS 133 0.0095
718 ILEUS 118 0.0095
719 HEPATOTOXICITY 211 0.0095
720 GLYCOSYLATED HAEMOGLOBIN INCREASED 239 0.0095
721 UPPER RESPIRATORY TRACT INFECTION 437 0.0094
722 HYPOXIA 333 0.0094
723 ADVERSE DRUG REACTION 846 0.0094
724 SKIN LESION 257 0.0094
725 ABSCESS 149 0.0093
726 SPLENOMEGALY 109 0.0093
727 URINARY TRACT INFECTION 1584 0.0093
728 NEPHROPATHY TOXIC 104 0.0093
729 PRURITUS 3540 0.0092
730 AGITATION 676 0.0092
731 RESPIRATORY DISTRESS 254 0.0092
732 CANDIDA INFECTION 155 0.0092
733 HEADACHE 5750 0.0092
734 ENCEPHALOPATHY 225 0.0092
735 SPEECH DISORDER 478 0.0091
736 CHRONIC KIDNEY DISEASE 693 0.0091
737 FLATULENCE 515 0.0091
738 RED BLOOD CELL COUNT DECREASED 259 0.0090
739 BLOOD TEST ABNORMAL 127 0.0090
740 SMALL INTESTINAL OBSTRUCTION 111 0.0090
741 ADVERSE EVENT 828 0.0090
742 SOMNOLENCE 1807 0.0090
743 PARANOIA 154 0.0089
744 CEREBROVASCULAR ACCIDENT 1511 0.0089
745 BRONCHOSPASM 127 0.0089
746 MENTAL IMPAIRMENT 215 0.0089
747 THERAPEUTIC RESPONSE DECREASED 537 0.0088
748 SKIN REACTION 124 0.0088
749 SNEEZING 197 0.0088
750 RESPIRATORY FAILURE 640 0.0088
751 PREMATURE BABY 264 0.0088
752 POLLAKIURIA 365 0.0087
753 RETCHING 186 0.0087
754 HEPATIC FAILURE 263 0.0087
755 TOOTH INFECTION 115 0.0087
756 COMA 415 0.0087
757 INTERVERTEBRAL DISC PROTRUSION 190 0.0087
758 BRAIN FOG 136 0.0087
759 INTENTIONAL SELF-INJURY 175 0.0087
760 PARALYSIS 124 0.0087
761 OSTEONECROSIS OF JAW 213 0.0086
762 INTENTIONAL OVERDOSE 549 0.0086
763 BRONCHITIS 633 0.0085
764 FEBRILE NEUTROPENIA 565 0.0085
765 ANOSMIA 123 0.0085
766 CARDIOVASCULAR DISORDER 215 0.0085
767 PSORIASIS 1106 0.0085
768 EYE HAEMORRHAGE 113 0.0085
769 EYELID OEDEMA 98 0.0084
770 THROAT TIGHTNESS 228 0.0084
771 CATARACT 500 0.0084
772 GENERALISED TONIC-CLONIC SEIZURE 138 0.0083
773 HAEMORRHOIDS 162 0.0083
774 DEAFNESS 217 0.0083
775 PRURITUS GENERALISED 179 0.0083
776 HEAD DISCOMFORT 146 0.0082
777 SUICIDE ATTEMPT 500 0.0082
778 UNDERDOSE 600 0.0082
779 BACK PAIN 1900 0.0082
780 ORAL PAIN 183 0.0082
781 MUSCLE TIGHTNESS 132 0.0081
782 FOETAL EXPOSURE DURING PREGNANCY 662 0.0081
783 CARDIAC FAILURE CONGESTIVE 654 0.0081
784 RASH ERYTHEMATOUS 389 0.0081
785 CONSTIPATION 1769 0.0081
786 OFF LABEL USE 6993 0.0080
787 RHINORRHOEA 515 0.0080
788 LACRIMATION INCREASED 240 0.0079
789 ABNORMAL WEIGHT GAIN 98 0.0079
790 SKIN DISORDER 264 0.0079
791 BLOOD GLUCOSE ABNORMAL 146 0.0079
792 HALLUCINATION, AUDITORY 125 0.0079
793 LYMPHADENOPATHY 277 0.0078
794 MOVEMENT DISORDER 251 0.0078
795 BLOOD TRIGLYCERIDES INCREASED 138 0.0078
796 ALTERED STATE OF CONSCIOUSNESS 169 0.0078
797 PSYCHOMOTOR HYPERACTIVITY 129 0.0078
798 SCHIZOPHRENIA 94 0.0077
799 ANAPHYLACTIC SHOCK 198 0.0077
800 ANXIETY 2174 0.0076
801 THYROID DISORDER 117 0.0076
802 PULMONARY MASS 113 0.0076
803 INJECTION SITE REACTION 520 0.0075
804 ERYTHEMA 1548 0.0075
805 INCORRECT PRODUCT ADMINISTRATION DURATION 163 0.0075
806 UVEITIS 102 0.0075
807 SPINAL FRACTURE 150 0.0075
808 TREMOR 1235 0.0074
809 POOR QUALITY SLEEP 160 0.0074
810 CLOSTRIDIUM DIFFICILE INFECTION 162 0.0074
811 SCAR 127 0.0074
812 DYSGEUSIA 545 0.0073
813 VIRAL INFECTION 243 0.0073
814 SECRETION DISCHARGE 91 0.0073
815 PNEUMOTHORAX 113 0.0071
816 PREMATURE DELIVERY 113 0.0071
817 HERNIA 137 0.0071
818 NEUTROPENIA 961 0.0071
819 VISION BLURRED 969 0.0071
820 INFLUENZA 787 0.0070
821 MYELODYSPLASTIC SYNDROME 102 0.0070
822 DIALYSIS 99 0.0070
823 HAEMORRHAGE 726 0.0069
824 DERMATITIS 145 0.0069
825 OSTEOPENIA 105 0.0069
826 GALLBLADDER DISORDER 122 0.0068
827 METASTASES TO LIVER 120 0.0068
828 PRODUCT QUALITY ISSUE 921 0.0068
829 TOXICITY TO VARIOUS AGENTS 1142 0.0068
830 AGGRESSION 338 0.0067
831 RENAL DISORDER 313 0.0067
832 PSYCHOTIC DISORDER 198 0.0067
833 LUNG INFECTION 104 0.0067
834 ACUTE MYELOID LEUKAEMIA 104 0.0067
835 CHILLS 781 0.0067
836 FEMUR FRACTURE 206 0.0066
837 METASTASES TO BONE 109 0.0066
838 NO ADVERSE EVENT 1203 0.0066
839 INFLUENZA LIKE ILLNESS 546 0.0066
840 SKIN EXFOLIATION 558 0.0066
841 BLOOD POTASSIUM DECREASED 198 0.0066
842 AGEUSIA 164 0.0066
843 PAIN IN JAW 186 0.0066
844 CHOKING 128 0.0066
845 FLUSHING 663 0.0065
846 HERPES ZOSTER 373 0.0065
847 CONJUNCTIVITIS 120 0.0065
848 POST PROCEDURAL COMPLICATION 124 0.0065
849 BONE MARROW FAILURE 131 0.0064
850 THROMBOSIS 518 0.0064
851 NEPHROLITHIASIS 295 0.0064
852 RASH GENERALISED 166 0.0064
853 DYSSTASIA 187 0.0064
854 STAPHYLOCOCCAL INFECTION 211 0.0064
855 VISUAL ACUITY REDUCED 212 0.0064
856 RASH MACULAR 223 0.0064
857 SKIN CANCER 137 0.0064
858 INTESTINAL OBSTRUCTION 239 0.0063
859 SEDATION 166 0.0063
860 GLAUCOMA 122 0.0063
861 PAIN OF SKIN 170 0.0063
862 BONE DISORDER 115 0.0063
863 TOOTH DISORDER 140 0.0063
864 SKIN DISCOLOURATION 289 0.0063
865 DYSKINESIA 255 0.0063
866 EYE SWELLING 233 0.0063
867 BONE PAIN 365 0.0062
868 PHOTOPHOBIA 117 0.0062
869 TREATMENT NONCOMPLIANCE 339 0.0062
870 THROAT IRRITATION 277 0.0062
871 CARDIO-RESPIRATORY ARREST 256 0.0061
872 PANIC ATTACK 223 0.0061
873 LIMB INJURY 166 0.0061
874 SEIZURE 705 0.0061
875 NEEDLE ISSUE 177 0.0061
876 ACUTE RESPIRATORY DISTRESS SYNDROME 107 0.0060
877 INTENTIONAL PRODUCT MISUSE 529 0.0060
878 SUICIDAL IDEATION 551 0.0060
879 DYSPHONIA 352 0.0060
880 TOOTHACHE 108 0.0060
881 FOOT FRACTURE 113 0.0060
882 RASH PAPULAR 133 0.0059
883 COVID-19 1040 0.0059
884 BLOOD GLUCOSE INCREASED 1113 0.0059
885 ANKLE FRACTURE 91 0.0059
886 ORAL HERPES 114 0.0058
887 CARDIAC DISORDER 546 0.0058
888 HOT FLUSH 439 0.0058
889 DRUG ABUSE 484 0.0058
890 ERUCTATION 112 0.0058
891 OVERDOSE 1232 0.0057
892 OSTEOMYELITIS 103 0.0057
893 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1016 0.0056
894 NEUROPATHY PERIPHERAL 528 0.0055
895 BLOOD GLUCOSE DECREASED 266 0.0055
896 MENTAL DISORDER 240 0.0055
897 EYE PRURITUS 182 0.0054
898 NEUTROPHIL COUNT DECREASED 219 0.0054
899 MALIGNANT NEOPLASM PROGRESSION 543 0.0053
900 BLINDNESS 216 0.0053
901 LOCAL SWELLING 92 0.0053
902 PERITONITIS 109 0.0053
903 BURNING SENSATION 367 0.0052
904 EYE PAIN 295 0.0052
905 MUSCULOSKELETAL DISORDER 99 0.0052
906 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 121 0.0052
907 INJECTION SITE MASS 191 0.0052
908 MIDDLE INSOMNIA 96 0.0051
909 HIP FRACTURE 165 0.0051
910 KIDNEY INFECTION 100 0.0051
911 DRUG INEFFECTIVE 6700 0.0051
912 GASTRIC DISORDER 174 0.0051
913 NASAL CONGESTION 297 0.0050
914 UPPER LIMB FRACTURE 100 0.0050
915 ABNORMAL BEHAVIOUR 198 0.0050
916 HYPOACUSIS 214 0.0050
917 EXTRAPYRAMIDAL DISORDER 122 0.0049
918 NEOPLASM PROGRESSION 168 0.0048
919 DISEASE RECURRENCE 228 0.0048
920 MOOD ALTERED 130 0.0048
921 NERVOUSNESS 249 0.0048
922 SKIN FISSURES 91 0.0047
923 PLATELET COUNT DECREASED 492 0.0046
924 FEELING ABNORMAL 1097 0.0046
925 PRODUCT SUBSTITUTION ISSUE 258 0.0045
926 RESPIRATORY ARREST 123 0.0045
927 GYNAECOMASTIA 138 0.0045
928 HYPERSOMNIA 124 0.0043
929 ABNORMAL DREAMS 119 0.0043
930 ABASIA 105 0.0042
931 NERVOUS SYSTEM DISORDER 131 0.0042
932 DISEASE PROGRESSION 489 0.0041
933 FEAR 111 0.0041
934 DRY EYE 204 0.0041
935 LUNG NEOPLASM MALIGNANT 167 0.0041
936 CONVULSION 230 0.0040
937 RENAL INJURY 118 0.0040
938 PROCEDURAL PAIN 108 0.0039
939 FUNGAL INFECTION 129 0.0039
940 THERAPEUTIC RESPONSE SHORTENED 128 0.0039
941 HEPATIC FUNCTION ABNORMAL 144 0.0039
942 OCULAR HYPERAEMIA 183 0.0039
943 WHITE BLOOD CELL COUNT DECREASED 416 0.0038
944 MENTAL STATUS CHANGES 103 0.0037
945 DRUG ADMINISTRATION ERROR 111 0.0036
946 ANGER 122 0.0036
947 MOOD SWINGS 114 0.0036
948 ILLNESS 366 0.0035
949 IRRITABILITY 212 0.0035
950 PROSTATE CANCER 273 0.0034
951 DRY SKIN 450 0.0034
952 HOSPITALISATION 506 0.0033
953 CRYING 116 0.0032
954 EYE DISORDER 102 0.0031
955 WITHDRAWAL SYNDROME 130 0.0031
956 DEVICE DISLOCATION 130 0.0030
957 OSTEONECROSIS 91 0.0028
958 PLASMA CELL MYELOMA 108 0.0028
959 SKIN IRRITATION 126 0.0027
960 DEATH 2305 0.0027
961 NEOPLASM MALIGNANT 175 0.0026
962 INJECTION SITE BRUISING 190 0.0024
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
964 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 151 0.0021
965 DRUG EFFECT DECREASED 114 0.0021
966 INJECTION SITE SWELLING 162 0.0021
967 SKIN BURNING SENSATION 150 0.0021
968 INJECTION SITE HAEMORRHAGE 165 0.0021
969 THERAPY CESSATION 106 0.0021
970 INCORRECT DOSE ADMINISTERED 462 0.0020
971 EMOTIONAL DISTRESS 241 0.0020
972 PRODUCT DOSE OMISSION 129 0.0020
973 EYE IRRITATION 112 0.0019
974 SURGERY 114 0.0019
975 COMPLETED SUICIDE 162 0.0019
976 PRODUCT DOSE OMISSION ISSUE 562 0.0019
977 MULTIPLE SCLEROSIS 91 0.0019
978 BREAST CANCER 176 0.0019
979 UNEVALUABLE EVENT 142 0.0019
980 INJECTION SITE PAIN 569 0.0019
981 DEVICE MALFUNCTION 125 0.0018
982 MULTIPLE SCLEROSIS RELAPSE 112 0.0016
983 INJECTION SITE PRURITUS 109 0.0016
984 BLADDER CANCER 89 0.0015
985 ACNE 106 0.0014
986 INJECTION SITE ERYTHEMA 172 0.0014
987 THERAPY INTERRUPTED 90 0.0013
988 DRUG DOSE OMISSION 200 0.0012
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 223 0.0011
990 DEVICE ISSUE 94 0.0010
991 DRUG WITHDRAWAL SYNDROME 91 0.0010
992 DRUG DEPENDENCE 153 0.0010